WellDoc has scored a deal with Samsung to integrate its consumer diabetes health app, BlueStar C, with the recently launched Samsung Health platform. The partnership also “covers” Samsung Gear smartwatches and fitness trackers.
“Our enhanced partnership with WellDoc gives us an opportunity to serve global consumers, who we believe are ready to embrace the combined health innovations that our companies plan to offer,” Suntae Jung, Vice President of Services R&D Team at Samsung Mobile Communications Business, said in a statement.
BlueStar C is the consumer version of WellDoc’s suite of diabetes product; it is a diabetes health tool designed to aid individuals living with diabetes in managing their chronic condition.
The app/service features feedback and messaging, and is driven by the same decision support engine and analytics as WellDoc’s original BlueStar platform, and shares many of the same key features but with a distinct lifestyle focus. Specifically, BlueStar C offers real-time support for users in their day-to-day diabetes self-care; easy tracking of blood glucose readings, food, medications, physical activity and sleep; videos and other resources to help improve daily lifestyle choices; and a progress report that can be shared with family members or health care teams.
“Samsung is both an investor in — and an ideal partner for — WellDoc, so it is incredibly rewarding for us to take our collaboration to the next level. Through this commercial agreement, Samsung becomes a distribution channel for WellDoc, and Samsung Health serves as a platform for BlueStar C,” said Kevin McRaith, CEO of WellDoc.
Beyond Samsung, WellDoc is also collaborating with other leading healthcare and technology companies, such as LifeScan, one of the Johnson & Johnson Diabetes Care Companies, the American Association of Diabetes Educators (AADE), and the Ontario Telemedicine Network (OTN).